Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier
WebMD

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine
WebMD

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion
    WebMD

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community
    WebMD

    Community

    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Epilepsy Health Center

Font Size
A
A
A

Epilepsy Drug Dilantin May Speed Bone Loss

Study Shows Young Women Taking Dilantin May Be at Long-Term Risk for Fractures
By
WebMD Health News
Reviewed by Louise Chang, MD

April 30, 2008 -- Young women taking the common epilepsy drug Dilantin may risk bone loss and fracture with long-term use.

A new study shows young women taking phenytoin (also commonly known as Dilantin) for one year lost 2.6% of the bone density in the femoral neck -- the upper part of the thigh bone near the hip joint. It's a common and dangerous site for fractures among the elderly.

Although previous studies have shown use of epilepsy drugs can have negative effects on bone mineral density (BMD) and bone metabolism (how quickly old bone is turned over by new bone), researchers say this is one of the first studies to look at the long-term effect of individual epilepsy drugs on bone loss.

"This is a significant amount of bone loss and raises serious concerns about the long-term effects of taking phenytoin in young women with epilepsy," says researcher Alison M. Pack, MD, with Columbia University in New York, in a news release. "This amount of bone loss, especially it if continues over the long term, could put these women at increased risk of fractures after menopause."

Checking for Bone Mineral Density

In the study, researchers followed 93 premenopausal women (age 18-40) taking one of four different epilepsy drugs: carbamazepine (also known with brand names Tegretol and Carbatrol), lamotrigine (Lamictal), valproate (Depakene), and Dilantin, for one year. Bone mineral density of the spine and two areas of the hip (femoral neck and total hip) were measured at the start and end of the study.

The results, published in Neurology, showed that women taking Dilantin experienced an average of 2.6% bone loss in the femoral neck only. No significant bone loss was found among those taking the other three epilepsy drugs.

Bone turnover markers were unchanged among the other groups, but women taking Dilantin experienced a decline in at least one marker.

Researchers say the women in the study did not have other risk factors for bone loss, were physically active, and reported high levels of calcium intake (more than 1,000 milligrams a day), which raises concerns about using Dilantin as a sole therapy for epilepsy.

Today on WebMD

human head and brain waves
Causes, symptoms, and treatments.
Grand mal seizure
How is each one different?
 
marijuana plant
CBD, a plant chemical, may cut down seizures.
prescription bottle
Which medication is right for you?
 
Seizures Driving
Article
Questions for Doctor Epilepsy
Article
 
Graces Magic Diet
Article
Pills spilling from bottle in front of clock
Article
 
first aid kit
Article
Caring Child Epilepsy
Article
 
Making Home Safe
Article
epilepsy monitoring
Article